These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Characteristics of H3K27M-mutant diffuse gliomas with a non-midline location. Guidara S; Seyve A; Poncet D; Leonce C; Bringuier PP; McLeer A; Sturm D; Cartalat S; Picart T; Ferrari A; Hench J; Frank S; Meyronet D; Ducray F; Barritault M J Neurooncol; 2024 Sep; 169(2):391-398. PubMed ID: 38937309 [TBL] [Abstract][Full Text] [Related]
3. Common molecular features of H3K27M DMGs and PFA ependymomas map to hindbrain developmental pathways. Pun M; Pratt D; Nano PR; Joshi PK; Jiang L; Englinger B; Rao A; Cieslik M; Chinnaiyan AM; Aldape K; Pfister S; Filbin MG; Bhaduri A; Venneti S Acta Neuropathol Commun; 2023 Feb; 11(1):25. PubMed ID: 36759899 [TBL] [Abstract][Full Text] [Related]
4. Identification of prognostic markers in diffuse midline gliomas H3K27M-mutant. Dufour C; Perbet R; Leblond P; Vasseur R; Stechly L; Pierache A; Reyns N; Touzet G; Le Rhun E; Vinchon M; Maurage CA; Escande F; Renaud F Brain Pathol; 2020 Jan; 30(1):179-190. PubMed ID: 31348837 [TBL] [Abstract][Full Text] [Related]
5. Diffuse midline glioma-H3K27M mutant. A novel entity with a defining and specific IHC marker. Agarwal P; Aiyer HM Indian J Pathol Microbiol; 2021; 64(2):351-353. PubMed ID: 33851633 [TBL] [Abstract][Full Text] [Related]
6. Significance of H3K27M Mutation in "Nonmidline" High-Grade Gliomas of Cerebral Hemispheres. La Rocca G; Sabatino G; Altieri R; Signorelli F; Ricciardi L; Gessi M; Della Pepa GM World Neurosurg; 2019 Nov; 131():174-176. PubMed ID: 31415896 [TBL] [Abstract][Full Text] [Related]
7. STAT3 is a biologically relevant therapeutic target in H3K27M-mutant diffuse midline glioma. Zhang L; Nesvick CL; Day CA; Choi J; Lu VM; Peterson T; Power EA; Anderson JB; Hamdan FH; Decker PA; Simons R; Welby JP; Siada R; Ge J; Kaptzan T; Johnsen SA; Hinchcliffe EH; Daniels DJ Neuro Oncol; 2022 Oct; 24(10):1700-1711. PubMed ID: 35397475 [TBL] [Abstract][Full Text] [Related]
8. Four methods to analyze H3K27M mutation in diffuse midline gliomas. Zhao H; Fang X; Xue B Pathol Res Pract; 2020 Sep; 216(9):153065. PubMed ID: 32825938 [TBL] [Abstract][Full Text] [Related]
9. Liquid biopsy in H3K27M diffuse midline glioma. Patel J; Aittaleb R; Doherty R; Gera A; Lau B; Messinger D; Wadden J; Franson A; Saratsis A; Koschmann C Neuro Oncol; 2024 May; 26(Supplement_2):S101-S109. PubMed ID: 38096156 [TBL] [Abstract][Full Text] [Related]
10. H3K27M-mutant diffuse midline glioma presenting as synchronous lesions involving pineal and suprasellar region: A case report and literature review. Lim JX; Leong A; Tan AP; Tan CL; Nga VDW J Clin Neurosci; 2020 Nov; 81():144-148. PubMed ID: 33222904 [TBL] [Abstract][Full Text] [Related]
11. Immunostaining of Increased Expression of Enhancer of Zeste Homolog 2 (EZH2) in Diffuse Midline Glioma H3K27M-Mutant Patients with Poor Survival. Karlowee V; Amatya VJ; Takayasu T; Takano M; Yonezawa U; Takeshima Y; Sugiyama K; Kurisu K; Yamasaki F Pathobiology; 2019; 86(2-3):152-161. PubMed ID: 31096221 [TBL] [Abstract][Full Text] [Related]
12. A H3K27M-targeted vaccine in adults with diffuse midline glioma. Grassl N; Poschke I; Lindner K; Bunse L; Mildenberger I; Boschert T; Jähne K; Green EW; Hülsmeyer I; Jünger S; Kessler T; Suwala AK; Eisele P; Breckwoldt MO; Vajkoczy P; Grauer OM; Herrlinger U; Tonn JC; Denk M; Sahm F; Bendszus M; von Deimling A; Winkler F; Wick W; Platten M; Sahm K Nat Med; 2023 Oct; 29(10):2586-2592. PubMed ID: 37735561 [TBL] [Abstract][Full Text] [Related]
13. Identification of a differentiation stall in epithelial mesenchymal transition in histone H3-mutant diffuse midline glioma. Sanders LM; Cheney A; Seninge L; van den Bout A; Chen M; Beale HC; Kephart ET; Pfeil J; Learned K; Lyle AG; Bjork I; Haussler D; Salama SR; Vaske OM Gigascience; 2020 Dec; 9(12):. PubMed ID: 33319914 [TBL] [Abstract][Full Text] [Related]
14. A comprehensive genomic study of 390 H3F3A-mutant pediatric and adult diffuse high-grade gliomas, CNS WHO grade 4. Williams EA; Brastianos PK; Wakimoto H; Zolal A; Filbin MG; Cahill DP; Santagata S; Juratli TA Acta Neuropathol; 2023 Sep; 146(3):515-525. PubMed ID: 37524847 [TBL] [Abstract][Full Text] [Related]
15. Prediction of H3K27M mutation status of diffuse midline gliomas using MRI features. Chauhan RS; Kulanthaivelu K; Kathrani N; Kotwal A; Bhat MD; Saini J; Prasad C; Chakrabarti D; Santosh V; Uppar AM; Srinivas D J Neuroimaging; 2021 Nov; 31(6):1201-1210. PubMed ID: 34189806 [TBL] [Abstract][Full Text] [Related]
16. Detection of Histone H3 mutations in cerebrospinal fluid-derived tumor DNA from children with diffuse midline glioma. Huang TY; Piunti A; Lulla RR; Qi J; Horbinski CM; Tomita T; James CD; Shilatifard A; Saratsis AM Acta Neuropathol Commun; 2017 Apr; 5(1):28. PubMed ID: 28416018 [TBL] [Abstract][Full Text] [Related]
17. Transcriptomic and epigenetic profiling of 'diffuse midline gliomas, H3 K27M-mutant' discriminate two subgroups based on the type of histone H3 mutated and not supratentorial or infratentorial location. Castel D; Philippe C; Kergrohen T; Sill M; Merlevede J; Barret E; Puget S; Sainte-Rose C; Kramm CM; Jones C; Varlet P; Pfister SM; Grill J; Jones DTW; Debily MA Acta Neuropathol Commun; 2018 Nov; 6(1):117. PubMed ID: 30396367 [TBL] [Abstract][Full Text] [Related]
18. Histone-mutant glioma presenting as diffuse leptomeningeal disease. Nadkarni T; Hamilton K; Niazi F; Ward M; Okakpu U; Castellani RJ; Prisneac I; Sener U CNS Oncol; 2021 Sep; 10(3):CNS75. PubMed ID: 34469205 [TBL] [Abstract][Full Text] [Related]
19. Targeted therapy with anlotinib for a H3K27M mutation diffuse midline glioma patient with PDGFR-α mutation: a case report. Wang Q; Niu W; Pan H Acta Neurochir (Wien); 2022 Aug; 164(8):2063-2066. PubMed ID: 34812950 [TBL] [Abstract][Full Text] [Related]
20. Differences in survival prognosticators between children and adults with H3K27M-mutant diffuse midline glioma. Gong X; Kuang S; Deng D; Wu J; Zhang L; Liu C CNS Neurosci Ther; 2023 Dec; 29(12):3863-3875. PubMed ID: 37311690 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]